lockDisease Awareness / DocumentThalassemia Backgrounder
Thalassemia refers to a diverse family of genetic disorders characterized by an underproduction of hemoglobin, a protein in red blood cells that carries oxygen.
lockCorporate Responsibility / Fact SheetHealthy Family fact sheet
Despite progress, billions of people still live at the bottom of the pyramid and lack access to essential healthcare. Our Healthy Family programs aim at expanding access to community education, improved infrastructure and affordable healthcare products in India, Vietnam and Kenya – in a sustainable way.
lockCorporate Responsibility / Fact SheetAccess fact sheet
The burden of noncommunicable diseases is increasing in the developing world, where people often have limited resources to get the care they need. Novartis Access aims to bring affordable treatments for key chronic diseases like cardiovascular diseases, diabetes and cancer to patients in lower-income countries.
lockDocumentWhat is non-alcoholic steatohepatitis (NASH)?
Non-alcoholic steatohepatitis (NASH) is a more severe, progressive form of non-alcoholic fatty liver disease (NAFLD). The prevalence of NAFLD in Western countries is 20-30%, and it is estimated that 2-3% of the population has NASH.
ImagelockLocations / ImageNovartis Pavillon Rendering 7
The new Novartis Pavillon on the Novartis Campus in Basel is home to the interactive exhibition “Wonders of Medicine” and many other exciting offers.
ImagelockLeadership / ImageKaren L. Hale
Chief Legal Officer since May, 2021
Member of the Executive Committee
VideolockScience & Innovation / B RollNovartis production and manufacturing B-roll (Video)
This B-roll includes a collection of footage of Novartis pharmaceutical manufacturing, production and packaging.
VideolockLocations / B RollNovartis Campus Walkway
VideolockLocations / B RollManufacturing Facility Stein (CH)
Manufacturing process of a cell and gene therapy (CAR-T)